Skip to main content
. 1998 Dec 1;18(23):10150–10156. doi: 10.1523/JNEUROSCI.18-23-10150.1998

Fig. 5.

Fig. 5.

Changes (% ± SEM) of the firing activity of quisqualate-activated dorsal hippocampus CA3 pyramidal neurons after intravenous injection of WAY 100635 (100 μg/kg) in control rats (CTL) and in rats treated with imipramine (IMI, t = −6.74,df = 17, p < 0.01), paroxetine (PRX, t = −4.71,df = 17, p < 0.01), mirtazapine (MIR, t = −5.86,df = 22, p < 0.01), befloxatone (BFX, t = −3.37,df = 18, p < 0.01), gepirone (GEP, t = −8.95,df = 17, p < 0.01), chlorpromazine (CPZ, t = −0.77,df = 17, p > 0.4), or pertussis toxin treatment (PTX, t = 0.44, df = 16, p > 0.6) and receiving single (1-ECS, t = 0.34,df = 18, p > 0.3) or multiple electroconvulsive shocks (7-ECS, t = −7.31, df = 17, p < 0.01), or both multiple electroconvulsive shocks and pertussis toxin treatment (7-ECS + PTX, t = 0.18,df = 17, p > 0.8). Thenumber for each column indicates the number of rats tested.